For the Quarter Ending December 2022
North America
Over the first half of the fourth quarter, Epinephrine prices gradually increased at a moderate rate in North America. End-user demand from the pharmaceutical industry kept Epinephrine costs on the sturdy end.
Additionally, there was a steep decline in supply chain disruption in the six months leading up to November across several measures, including shipping costs, which further strengthened the Epinephrine market in an upward direction.
However, towards the end of q4, they started to fall precipitously due to a major decrease in their offtakes and New year breaks. Prices for Epinephrine stayed on the North side, with the settlement at USD 2448000 /MT CFR Los Angeles.
APAC
In the fourth quarter of 2022, Epinephrine prices in the Asia Pacific area, particularly in China, plummet by the end of December. However, prices remained on the upper side throughout the initial half of q4 due to increased downstream demand balanced with adequate supplies among market participants. On the other hand, the ease in supply chain disruption in November compared to October, including the lower shipping costs, encouraged the traders and suppliers to raise their quotations. With the year ending 2022 concluding, China's production activities started to decline, particularly after November, due to an increase in COVID-19 instances and a reduction in freight costs, supporting Epinephrine's price trend in China. Overall, the Epinephrine costs noted in the middle of the fourth were assembled at USD 2318500/MT FOB Shanghai in China.
Europe
The Epinephrine market in Europe followed a similar trajectory to that in Asia Pacific in the fourth quarter of 2022. Due to a rise in demand from the end-user pharmaceutical business, the market trend started off well up until November and reached an assembly price of USD 2491500/MT CFR Hamburg in Germany. After November, Epinephrine inquiries from the downstream industry started to decline dramatically, which reinforced the drug's weaker price trend because market participants had plenty of supply and little to no demand. Also, fresher quotations declined in December because of suppliers' high stock levels brought on by the market closure.
For the Quarter Ending September 2022
North America
Prices of Epinephrine API showcased a stable market sentiment in the North American region during the third quarter of 2022, owing to the sufficient inventories and weaker demand in the regional market. During the H1 of Q3, the market saw an increase in demand, which further weighed on the high prices of Epinephrine API across the regional market. On the other hand, a rise in the energy cost and crude oil value due to the geopolitical tension between Russia and Ukraine kept the cost on the higher side. At the end of Q3, the prices went down owing to weaker demand, which resulted in stockpiling of inventories with the traders. Overall, demand for the Epinephrine API in the various end-user market has remained stable in terms of demand and supply side in Q3, and the prices recorded were assessed at USD 2440000/MT CFR Los Angeles.
Asia-Pacific
Epinephrine prices in Asia-Pacific have witnessed a stable market sentiment. At the onset of Q3, prices declined steadily due to weaker demand and sufficient supplies. In addition, a balanced supply and demand in the market kept the prices of Epinephrine API consistent. On the demand front, moderate offtake from various end-user, notably the pharmaceutical and biopharmaceutical sector, was one of the major factors for steady Epinephrine API prices. Also, transport cost disruption, cargo shortages, and the rerouting of transport vehicles supported the market sentiments of Epinephrine in the region. Furthermore, towards the termination of Q3, the prices went down significantly in September and were settled at USD 2310000/MT FOB Shanghai in China.
Europe
In the third quarter of 2022, the prices of Epinephrine API remained sturdy in the European market as it followed similar market sentiments as those of the APAC region. The demand for Epinephrine API-based drugs has decreased, resulting in stockpiling stocks with domestic merchants in the market. On the supply front, the supply remained consistent, but the queries from the customers were low to moderate, which affects the price tendency of Epinephrine in Europe. Overall, the demand for the product in the end-user pharmaceutical witnessed was firm throughout the q3 of 2022. Furthermore, at the end of the third quarter, the prices demonstrated for Epinephrine were settled at USD 2485000/MT CFR Hamburg in Germany.
For the Quarter Ending June 2022
North America
Prices of Epinephrine have showcased a negative market sentiment in the North American region during the second quarter of 2022, owing to the sufficient inventories in the regional market. on the onset of q2 the market saw an increase in upstream feed prices, which further weighed on the high prices of Epinephrine API across the regional market. On the other hand, a shot-up in the energy cost and crude oil value because of the geopolitical tension between Russia and Ukraine led to the high maritime cost, which further provoked the Epinephrine prices in the region. In the mid of q2 the prices went down owing to weaker demand, which resulted in stockpiling of inventories with the suppliers. Overall, demand for the Epinephrine API in the various end-user market has remained mixed in Q2 and the prices recorded were assessed at USD 2418000/MT CFR Los Angeles.
Asia-Pacific
Epinephrine prices in Asia-Pacific have witnessed a mixed market sentiment. On the onset of Q2 the prices increased due to limited supplies in the regional market. In addition, a gap between supply and demand occurred in the market, resulting in a hike in the prices of Epinephrine API. On the demand front, high offtake from various end-user, notably the pharmaceutical and biopharmaceutical sector, was one of the major factors driving the Epinephrine API prices. Also, transport cost disruption, cargo shortages coupled with the rerouting of transport vehicles supported the market sentiments of Epinephrine in the region. Furthermore, towards the termination of q2 the prices went down significantly in June and the prices witnessed for Epinephrine were settled at USD 2310000/MT FOB Shanghai in China.
Europe
In the second quarter of 2022, the prices of Epinephrine API remained at a weaker side in the European market. The demand for Epinephrine API-based drugs has decreased as which resulted in the stockpiling of stocks with the domestic merchants in the regional market. on the supply front the supply remained consistent but the queries from the customers declined which affects the market sentiments of Epinephrine in Europe. Overall, the demand for the product in the end-user pharmaceutical witnessed were low in Q2. These facets governed the market sentiments of Epinephrine in the European market. Furthermore, towards the end of Q2 the prices recorded for Epinephrine were settled at USD 2496000/MT CFR Hamburg in Germany.
